More on Rimonabant for Obesity
Obesity is becoming a problem going out of hand. It is time to curtail the problem by resorting to some means or the other. Traditional obesity reduction methods like doing exercises and having a controlled diet are fast becoming a thing of the past. But one should never underestimate the potential of these past methods to curtail obesity.
Obesity is now the most common nutritional disorder in western industrialised countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from over consumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels.
Obesity is considered a mild inflammatory condition and predisposes individuals to an increased risk of developing many diseases. It has been recently suggested that a successful intervention to treat obesity is a therapy combining weight-reducing drugs with anti-inflammatory ones. In this scenario, rimonabant’s anti-obesity action is accompanied by favorable changes in markers for insulin resistance, C-reactive protein, adiponectin, tumor necrosis factor α (TNFα).
Obesity predisposes individuals to an increased risk of developing many diseases, including atherosclerosis, diabetes and some immune-mediated disorders. Importantly, obesity is associated with chronic inflammatory responses, such as arthritis and Crohn’s disease
Acomplia Rimonabant is a drug that can be used to aid weight loss. If you are overweight and have been unsuccessful in losing weight, Acomplia may be what you need to change the pattern of unsuccessfully trying to lose weight that you have been stuck in for so long. With the help of Acomplia, you can break your old habits and finally get on track to start losing weight.
Obesity is increasing at an alarming rate in developed countries; 34% of the United States population, for example, has a body mass index (BMI) >30, while fully 66% of the U.S. adult population is considered overweight. Abdominal obesity increases the risk of cardiovascular events, especially in the presence of the constellation of risk factors known as metabolic syndrome
The usual prescribed dosage of Acomplia (Rimonabant) is 20mg. Do not overdose it. Strictly adhere to your doctor’s prescription for a desirable weight loss.It is advisable to make your doctor well-informed regarding your medical history including any medication you may be engaged in. Pregnant women and nursing mothers should abstain from intake of Acomplia (Rimonabant).
Rimonabant is the first drug of a new class of medications that seems to reduce body weight and improve risk factors for diseases of the blood vessels and heart in people who are overweight or obese. We found four studies which evaluated weight loss, occurrence of disorders and adverse effects of treatment.
